House passes bill to reauthorize FDA user fee programs

Jun 09, 2022 - 02:53 PM
recissioin-legislation

The House yesterday voted 392-28 to pass legislation (H.R. 7667) that would reauthorize Food and Drug Administration user fee programs, which provide funding for the agency to review drugs, devices and biologics. Among other provisions, the bipartisan bill would include drugs on the FDA’s shortages list in a pilot program to designate advanced manufacturing technologies. The Senate Health, Education, Labor, and Pensions Committee will mark up their version of the bill Tuesday.

Related News Articles

Headline
Olympus expands recall of endoscope needles
Olympus has expanded a voluntary recall of its ViziShot 2 FLEX Needles due to complaints of device components ejecting or attaching during…
Headline
FDA identifies, issues Class 1 recalls
The Food and Drug Administration has identified a recall by Cook Medical of Zenith Alpha 2 Thoracic Endovascular Graft proximal components after Cook Medical…
Headline
FDA announces digital health services pilot 
The Food and Drug Administration announced Dec. 5 that it will launch the Technology-Enabled Meaningful Patient Outcomes for Digital Health Devices Pilot, or…
Headline
Permanent recall issued for Baxter ventilation system
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
FDA issues most serious recall for certain speed control dials used for wheelchairs
The Food and Drug Administration has identified a Class I recall of Max Mobility/Permobil SpeedControl Dials used with the SmartDrive MX2+ Power Assist Device…
Headline
HSCC issues guidance for updated cybersecurity model contract language for health care organizations, medical device manufacturers
The Health Sector Coordinating Council’s Cybersecurity Working Group Nov. 18 released a best practices guide for health care organizations and medical device…